Acacia Pharma

About

Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.

Cambridge,Cambridgeshire,United Kingdom
1 - 10

Highlights

Details

Last Funding Type: Debt Financing
Last Funding Money Raised: $30M
Industries: Biopharma,Biotechnology,Pharmaceutical
Founded date: Jan 1, 2006
Number Of Employee: 1 - 10
Operating Status: Active
Stock Symbol: epa:ACPH

Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$63.50M €40M

Acacia Pharma has raised a total of $63.50M €40M in funding over 2 rounds. Their latest funding was raised on Jul 2, 2018 from a Debt Financing round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 2, 2018	Debt Financing	$30M	1	—	—	Detail
Feb 21, 2018	IPO	€40M	—	—	—	Detail
Sep 3, 2013	Series B	$23.50M	5	F-Prime Capital Novo Holdings	—	Detail
Mar 31, 2011	Series A	$10M	2	Lundbeckfonden Ventures	—	Detail

Investments

Number of Investments

Number of Lead Investments

1

0

Acacia Pharma has made 1 investments. Their most recent investment was on Jun 4, 2020, when Cosmo Pharmaceuticals raised $25M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jun 4, 2020 Cosmo Pharmaceuticals	Post-IPO Debt	$25M	Biotechnology	—

Investors

Number of Lead Investors

Number of Investors

3

6

Acacia Pharma is funded by 6 investors. F-Prime Capital and Novo Holdings are the most recent investors.

Investor Name	Lead Investor	Funding Round
F-Prime Capital	Yes	Series B
Novo Holdings	Yes	Series B
Hercules Capital	—	Debt Financing
Eight Roads Ventures	—	Series B
Gilde Healthcare	—	Series B
Lundbeckfonden Ventures	—	Series B